Template Description
4hcu: CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
3mj2: X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BM Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-780
3mj2A
55%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALV
>3mj2A
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI
[Model]
4hcv: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
519-783
4hcvA
55%
>target
WEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT
>4hcvA
WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3t9t: CRYSTAL STRUCTURE OF BTK MUTANT (F435T,K596R) COMPLEXED WIIMIDAZO[1,5-A]QUINOXALINE Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
519-783
3t9tA
55%
>target
WEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT
>3t9tA
WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
4hct: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
517-783
4hctA
55%
>target
DKWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT
>4hctA
GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3qgw: CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-783
3qgwA
50%
>target
IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT
>3qgwA
IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGFP-----------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
3qgy: CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
519-783
3qgyA
49%
>target
-WEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT
>3qgyA
HMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
520-781
3qgyB
50%
>target
-EIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVA
>3qgyB
MVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTP----------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
1sm2: CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-783
1sm2A
49%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>1sm2A
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
521-782
1sm2B
49%
>target
IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>1sm2B
IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK-------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
1snx: CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 3.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-783
1snxA
49%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>1snxA
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
521-783
1snxB
49%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>1snxB
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
1snu: CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-783
1snuA
49%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>1snuA
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
521-782
1snuB
49%
>target
IHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>1snuB
IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK-------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
3v8w: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469 Solved by: X-RAY, Resolution: 2.27A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
518-783
3v8wA
47%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3v8wA
GSVIDPSELTFVQEIGSG--GLVHLGYWLNKDKVAIKTIRG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYER-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
518-783
3v8wB
47%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3v8wB
GSVIDPSELTFVQEIGSG--GLVHLGYWLNKDKVAIKTIRM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGPVK------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v8t: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
518-783
3v8tB
47%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3v8tB
GSVIDPSELTFVQEIGSG--GLVHLGYWLNKDKVAIKTIAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTP----------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v5l: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542 Solved by: X-RAY, Resolution: 1.86A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
518-781
3v5lC
47%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVA
>3v5lC
GSVIDPSELTFV---QEIGSGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTF---------------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
518-783
3v5lD
47%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3v5lD
GSVIDPSELTFVQEIGSG-QGLVHLGYWLNKDKVAIKTIRAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMFP----------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v5j: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090 Solved by: X-RAY, Resolution: 2.59A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
518-783
3v5jB
46%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT--
>3v5jB
GSVIDPSELTFVQEIGSG--GLVHLGYWLNKDKVAIKTIMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFPVK-------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL
[Model]
3emg: DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2- PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-780
3emgA
38%
>target
IHPMELMLME-ELGSGQFGVVRRGKWRG--SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALV--
>3emgA
LDRKLLTLEDKELGSGNFGTVKKGYYQMKVVKTVAVKILKL----KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY
[Model]
1xbb: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
1xbbA
37%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL------
>1xbbA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
4f4p: SYK IN COMPLEX WITH LIGAND LASW836 Solved by: X-RAY, Resolution: 2.37A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-784
4f4pA
37%
>target
IHPMELMLME-ELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL----
>4f4pA
LDRKLLTLEDKELGSGNFGTVKKGYVK---TVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG
[Model]
3fqs: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHR406 Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
3fqsA
37%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL------
>3fqsA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
3vf9: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC THIENOPYRAZOLYLINDOLE INHIBITOR 027 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-786
3vf9A
37%
>target
-IHPMELMLME-ELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD
>3vf9A
YLDRKLLTLEDKELGSGNFGTVKKGYQMKVVKTVAVKILPA---LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3srv: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLDIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-784
3srvA
36%
>target
-IHPMELMLMEELGSGQFGVVRRGKWRGSI---DTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL-
>3srvA
YLDRKLL-TLEDKELGNFGTVKKGYYQMKKVVKTVAVKILKA---LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV
[Model]
521-781
3srvB
37%
>target
-IHPMELMLME-ELGSGQFGVVRRGKWRGSI---DTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVA--
>3srvB
YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILP---ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD
[Model]
4fl1: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.79A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-786
4fl1A
37%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD
>4fl1A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
1xba: CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-786
1xbaA
37%
>target
--IHPMELMLME-ELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD-
>1xbaA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVVKTVAVKILPA---LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
1xbc: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-785
1xbcA
37%
>target
--IHPMELMLME-ELGSGQFGVVRRGKWRGSI---DTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLT--
>1xbcA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILPA---LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
4dfn: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHADAMANTYLPYRAZINE INHIBITOR Solved by: X-RAY, Resolution: 2.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-786
4dfnA
37%
>target
-EIHPMELMLM-EELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDD--QYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD-
>4dfnA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3fqe: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHYM193306 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
3fqeA
37%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL------
>3fqeA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
3vf8: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416 Solved by: X-RAY, Resolution: 2.08A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-785
3vf8A
36%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLD--DQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLT-
>3vf8A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVVKTVAVKILPA---LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3tud: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-OXO-2-(PHENYLAMINO)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-6-Y(TRIFLUOROMETHYL)BENZAMIDE Solved by: X-RAY, Resolution: 2.33A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
3tudA
35%
>target
-EIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL---
>3tudA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGKW----------------PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNH
[Model]
3tuc: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-1,2-DIHYDROCARBOXAMIDE Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
516-783
3tucA
35%
>target
--HDKWEIHPMELMLME-ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3tucA
IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLP-----------------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
4dfl: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHSULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR Solved by: X-RAY, Resolution: 1.98A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-785
4dflA
35%
>target
-EIHPMELMLM-EELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDD--QYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLT--
>4dflA
VYLDRKLLTLEDKELGSGTVKKGYYQMV--VKTVAVKILPA---LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3tub: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(6,7- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R,2S)-2- PHENYLCYCLOPROPYL)UREA Solved by: X-RAY, Resolution: 2.23A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
519-783
3tubA
35%
>target
-WEIHPMELMLM-EELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3tubA
EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLP-----------------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
3fqh: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHA 2-SUBSTITUTED 7-AZAINDOLE Solved by: X-RAY, Resolution: 2.26A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
531-784
3fqhA
36%
>target
--------ELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL-
>3fqhA
VYLDRKLLTLEDKELGTVKKGYYQMKKVVKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV
[Model]
517-783
3fqhB
35%
>target
---DKWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQT-
>3fqhB
VYLDRKLLTLEDKE----LGSTVKKGYYQMKKV-VKTVAVKILKPA--LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
3ppz: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH ST Solved by: X-RAY, Resolution: 2.99A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
516-782
3ppzA
34%
>target
-HDKWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHN--YIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQ-RGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>3ppzA
DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
517-782
3ppzB
33%
>target
--DKWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHN--YIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERV-QRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>3ppzB
DGDDMDIPWCDLNIKEKIG----ATVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3p86: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COSTAUROSPORINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-782
3p86A
32%
>target
-EIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSE---DDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHN--YIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERV-QRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>3p86A
MDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGTP------------------EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
518-782
3p86B
32%
>target
KWEIHPMELMLMEELGSGQFGVVRRGKWRGSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHN--YIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQ-RGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQ
>3p86B
DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKIL---------FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGTP------------------EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
4e1z: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
4e1zA
31%
>target
----EIHPMELMLMEELGSGQFGVVRRGKWRG-----SIDTAVKMMKEGT--MSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTC---GKMPYGRLKN-----------TEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL-
>4e1zA
SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED-KSVQLVMEYVPLGSLRDYLPRH----CVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
4e20: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
4e20A
31%
>target
---EIHPMELMLMEELGSGQFGVVRRGKWRG-----SIDTAVKMMKEGTM--SEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTC---GKMPYGRLKNT-------EVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL-
>4e20A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED--SVQLVMEYVPLGSLRDYLPRH----CVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
3lxp: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
3lxpA
30%
>target
---EIHPMELMLMEELGSGQFGVVRRGKWRG---SIDTAVKMMKEGTM--SEDDFIEEAKVMTKLQHPNLVQLYGVCSK--HRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGR---------------LKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL--
>3lxpA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
3nz0: NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-785
3nz0A
30%
>target
---EIHPMELMLMEELGSGQFGVVRRGKWRG-----SIDTAVKMMKEGTM--SEDDFIEEAKVMTKLQHPNLVQLYGVCSKH--RPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRL-----KNTE----VVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLT-
>3nz0A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
3lxn: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-784
3lxnA
29%
>target
---EIHPMELMLMEELGSGQFGVVRRGKWRG-----SIDTAVKMMKEGTMS--EDDFIEEAKVMTKLQHPNLVQLYGVCSKH--RPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGR---------------LKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTL--
>3lxnA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--S--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
1bk2: A-SPECTRIN SH3 DOMAIN D48G MUTANT Solved by: X-RAY, Resolution: 2.01A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
1bk2A
29%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1bk2A
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NGRQGFVPAAYVKKLD
[Model]
2f2x: ALPHA-SPECTRIN SH3 DOMAIN R21G MUTANT Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
2f2xA
29%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP-
>2f2xA
ELVLALYDYQEKSPGEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKL
[Model]
1hd3: A-SPECTRIN SH3 DOMAIN F52Y MUTANT Solved by: X-RAY, Resolution: 1.98A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
1hd3A
29%
>target
-VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>1hd3A
GKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGYVPAAYVKKLD
[Model]
2cdt: ALPHA-SPECTRIN SH3 DOMAIN A56S MUTANT Solved by: X-RAY, Resolution: 2.54A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
2cdtA
29%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP-
>2cdtA
KLVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPASYVKKL
[Model]
3nyx: NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZTHIOPHENE INHIBITOR Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
520-785
3nyxA
29%
>target
--EIHPMELMLMEELGSGQFGVVRRGKWRG---SIDTAVKMMKEGTM--SEDDFIEEAKVMTKLQHPNLVQLYGVCSKH-RPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQ--YTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGR---------------LKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLT-
>3nyxA
PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQEKSLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
4glm: CRYSTAL STRUCTURE OF THE SH3 DOMAIN OF DNMBP PROTEIN [HOMO Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
346-399
4glmC
28%
>target
-LVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>4glmC
TYGVALYRFQALEPNELDFEVGDKIRILATLEDGWLEGSL-KGRTGIFPYRFVKLCP
[Model]
345-399
4glmD
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>4glmD
LTYGVALYRFQALEPNELDFEVGDKIRILATLEDGWLEGSL-KGRTGIFPYRFVKLCP
[Model]
345-399
4glmA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>4glmA
LTYGVALYRFQALEPNELDFEVGDKIRILATLEDGWLEGSL-KGRTGIFPYRFVKLCP
[Model]
345-399
4glmB
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>4glmB
LTYGVALYRFQALEPNELDFEVGDKIRILATLEDGWLEGSL-KGRTGIFPYRFVKLCP
[Model]
1qkw: ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, N47G MUTANT IN THE DISTAL LOOP. Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
1qkwA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1qkwA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-GDRQGFVPAAYVKKLD
[Model]
2jm8: R21A SPC-SH3 FREE Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
2jm8A
27%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2jm8A
MDETGKELVLALYDYQEKSPAEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
3m0s: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3CRYSTAL OBTAINED IN AMMONIUM SULPHATE AT PH 7 Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
3m0sA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>3m0sA
KELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1shg: CRYSTAL STRUCTURE OF A SRC-HOMOLOGY 3 (SH3) DOMAIN Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
1shgA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1shgA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1aey: ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, SOLUTION NMR, 15 STRUCTURES Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
1aeyA
27%
>target
-VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>1aeyA
GKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1m8m: , SOLID-STATE MAS NMR STRUCTURE OF THE A-SPECTRIN SH3 DOMAIN Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
1m8mA
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>1m8mA
ELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1u06: CRYSTAL STRUCTURE OF CHICKEN ALPHA-SPECTRIN SH3 DOMAIN Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
1u06A
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP-
>1u06A
ELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKL
[Model]
2nuz: CRYSTAL STRUCTURE OF ALPHA SPECTRIN SH3 DOMAIN MEASURED ATROOM TEMPERATURE Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
2nuzA
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP-
>2nuzA
ELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKL
[Model]
3m0p: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3CRYSTAL OBTAINED IN AMMONIUM SULPHATE AT PH 4. Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
3m0pA
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3m0pA
ELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
3m0q: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3CRYSTAL OBTAINED IN AMMONIUM SULPHATE AT PH 5. Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
3m0qA
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3m0qA
ELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
4fl2: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 2.19A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
405-786
4fl2A
30%
>target
----------------------------------------------------------------------------------------------------------------------------------------------------------LERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDRPVP-----P-----------TAGLSHDKWEIHPMELMLME-ELGSGQFGVVRRGKWRG---SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLD--DQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD
>4fl2A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLH---EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
406-504
4fl2A
27%
>target
--ERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPC-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
>4fl2A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH---GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3thk: STRUCTURE OF SH3 CHIMERA WITH A TYPE II LIGAND LINKED TO TTERMINAL Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
3thkA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK--
>3thkA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLDP
[Model]
345-400
3thkB
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK--
>3thkB
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLDP
[Model]
1uue: A-SPECTRIN SH3 DOMAIN (V44T, D48G MUTANT) Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
1uueA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1uueA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKTEV-NGRQGFVPAAYVKKLD
[Model]
2jm9: R21A SPC-SH3 BOUND Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
2jm9A
27%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2jm9A
MDETGKELVLALYDYQEKSPAEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
2f2w: ALPHA-SPECTRIN SH3 DOMAIN R21A MUTANT Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
2f2wA
27%
>target
KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2f2wA
ELVLALYDYQEKSPAEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1e6g: A-SPECTRIN SH3 DOMAIN A11V, V23L, M25I, V53I, V58L MUTANT Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
1e6gA
27%
>target
--VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>1e6gA
TGKELVLVLYDYQEKSPRELTIKKGDILTLLNSTNKDWWKVEV-NDRQGFIPAAYLKKLD
[Model]
3m0t: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3CRYSTAL OBTAINED IN AMMONIUM SULPHATE AT PH 9. Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
3m0tA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP-
>3m0tA
KELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKL
[Model]
2jma: R21A SPC-SH3:P41 COMPLEX Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-399
2jmaA
27%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2jmaA
MDETGKELVLALYDYQEKSPAEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
3i9q: CRYSTAL STRUCTURE OF THE TRIPLE MUTANT S19G-P20D-R21S OF ALPHA SPECTRIN SH3 DOMAIN Solved by: X-RAY, Resolution: 1.45A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
3i9qA
27%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3i9qA
KELVLALYDYQEKGDSEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
4fl3: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
405-786
4fl3A
30%
>target
----------------------------------------------------------------------------------------------------------------------------------------------------------LERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDRPV-PPT-----------AGLSHDKWEIHPMELMLM-EELGSGQFGVVRRGKWRGS---IDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQLALVAQTLTD
>4fl3A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLH---EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----------RAPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
406-505
4fl3A
26%
>target
--ERYEWYVGDMSRQRAESLLKQG-DKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCD-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
>4fl3A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH---GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
2f2v: ALPHA-SPECTRIN SH3 DOMAIN A56G MUTANT Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
343-399
2f2vA
26%
>target
----FVKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2f2vA
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAGYVKKLD
[Model]
1qkx: ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, N47A MUTANT IN THE DISTAL LOOP. Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
1qkxA
26%
>target
-VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1qkxA
GKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-ADRQGFVPAAYVKKLD
[Model]
3m0r: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3CRYSTAL OBTAINED IN AMMONIUM SULPHATE AT PH 6. Solved by: X-RAY, Resolution: 1.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
3m0rA
26%
>target
-VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3m0rA
GKELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
2lj3: PFBD: HIGH-THROUGHPUT STRATEGY OF BACKBONE FOLD DETERMINATSMALL WELL-FOLDED PROTEINS IN LESS THAN A DAY Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
343-400
2lj3A
26%
>target
----FVKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>2lj3A
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
3m0u: CRYSTAL STRUCTURE OF THE R21D MUTANT OF ALPHA-SPECTRIN SH3HEXAGONAL CRYSTAL OBTAINED IN SODIUM FORMATE AT PH 6.5. Solved by: X-RAY, Resolution: 1.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
3m0uA
26%
>target
-VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3m0uA
GKELVLALYDYQEKSPDEVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1pwt: THERMODYNAMIC ANALYSIS OF ALPHA-SPECTRIN SH3 AND TWO OF ITCIRCULAR PERMUTANTS WITH DIFFERENT LOOP LENGTHS: DISCERNING THE REASONS FOR RAPID FOLDING IN PROTEINS Solved by: X-RAY, Resolution: 1.77A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
343-400
1pwtA
26%
>target
---FVKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1pwtA
MGTGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLD
[Model]
1g2b: ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, CIRCULAR PERMUTANT, CUT AT N47-D48 Solved by: X-RAY, Resolution: 1.12A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-383
1g2bA
26%
>target
---------------------KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVK--
>1g2bA
MDRQGFVPAAYVKKLDSGTGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVN
[Model]
1tud: ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, CIRCULAR PERMUTANT, CUT AT N47-D48 Solved by: X-RAY, Resolution: 1.77A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-383
1tudA
26%
>target
-------------------KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVK--
>1tudA
RQGFVPAAYVKKLDSGTGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVN
[Model]
1h8k: A-SPECTRIN SH3 DOMAIN A11V, V23L, M25V, V53I, V58L MUTANT Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
1h8kA
25%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1h8kA
KELVLVLYDYQEKSPREVTVKKGDILTLLNSTNKDWWKVEV-DDRQGFIPAAYLKKLD
[Model]
2krn: HIGH RESOLUTION STRUCTURE OF THE SECOND SH3 DOMAIN OF CD2A Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-399
2krnA
25%
>target
----KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>2krnA
GSMGRQCKVLFDYSPQNEDELELIVGDVIDVIEEVEEGWWSGTL-NNKLGLFPSNFVKELE
[Model]
3ngp: HIGH RESOLUTION STRUCTURE OF ALPHA-SPECTRIN SH3 DOMAIN MUTREDESIGNED CORE Solved by: X-RAY, Resolution: 1.08A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
3ngpA
25%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>3ngpA
KELVLVLYDYQEKSPRELTVKKGDILTLLNSTNKDWWKIEV-NGRQGFVPAAYLKKLD
[Model]
1neg: CRYSTAL STRUCTURE ANALYSIS OF N-AND C-TERMINAL LABELED SH3DOMAIN OF ALPHA-CHICKEN SPECTRIN Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-411
1negA
24%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPKALLGLERYEWY
>1negA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEV-NDRQGFVPAAYVKKLA--AAWSHPQF
[Model]
2oaw: STRUCTURE OF SHH VARIANT OF "BERGERAC" CHIMERA OF SPECTRINSH3 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-400
2oawA
24%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2oawA
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKITVNGKTYERQGFVPAAYVKKLD
[Model]
345-400
2oawB
24%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2oawB
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKITVNGKTYERQGFVPAAYVKKLD
[Model]
345-400
2oawC
24%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2oawC
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKITVNGKTYERQGFVPAAYVKKLD
[Model]
345-400
2oawD
24%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2oawD
KELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKITVNGKTYERQGFVPAAYVKKLD
[Model]
1a81: CRYSTAL STRUCTURE OF THE TANDEM SH2 DOMAIN OF THE SYK KINASE BOUND TO A DUALLY TYROSINE-PHOSPHORYLATED ITAM Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
405-503
1a81I
27%
>target
-LERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSP-----------------------------------------------------------------------------------------------------------------------------------------------------------
>1a81I
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH---GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
404-504
1a81I
23%
>target
---------------------------------------------------------------------------------------------------------------------------------------------------------GLERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPC--
>1a81I
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLH---EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
405-503
1a81A
27%
>target
-LERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSP-----------------------------------------------------------------------------------------------------------------------------------------------------------
>1a81A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH---GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
405-503
1a81C
27%
>target
-LERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSP-----------------------------------------------------------------------------------------------------------------------------------------------------------
>1a81C
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAH---GRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
404-504
1a81A
23%
>target
---------------------------------------------------------------------------------------------------------------------------------------------------------GLERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPC--
>1a81A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLH---EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
404-504
1a81C
23%
>target
---------------------------------------------------------------------------------------------------------------------------------------------------------GLERYEWYVGDMSRQRAESLLKQ-GDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPC--
>1a81C
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLH---EGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKI
[Model]
1e7o: A-SPECTRIN SH3 DOMAIN A11V, V23L, M25V, V44I, V58L MUTATIO Solved by: X-RAY, Resolution: 3.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
1e7oA
23%
>target
--VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1e7oA
TGKELVLVLYDYQEKSPRELTVKKGDILTLLNSTNKDWWKIEV-NDRQGFVPAAYLKKLD
[Model]
2rmo: SOLUTION STRUCTURE OF ALPHA-SPECTRIN_SH3-BERGERAC FROM CHICKEN Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
2rmoA
23%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2rmoA
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKATANGKTYERQGFVPAAYVKKLD
[Model]
2rot: STRUCTURE OF CHIMERIC VARIANT OF SH3 DOMAIN- SHH Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
2rotA
23%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2rotA
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKITVNGKTYERQGFVPAAYVKKLD
[Model]
2dlm: SOLUTION STRUCTURE OF THE FIRST SH3 DOMAIN OF HUMAN VINEXI Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-401
2dlmA
23%
>target
-------KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPKA-----
>2dlmA
GSSGSSGKAARLKFDFQAQSPKELTLQKGDIVYIHKEVDKNWLEGEH-HGRLGIFPANYVEVLSGPSSG
[Model]
2kr3: SOLUTION STRUCTURE OF SHA-D Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-400
2kr3A
23%
>target
-----VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD-------ALGNVGYIPSNYVKPK-
>2kr3A
MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVKATANDKTYERQGFVPAAYVKKLD
[Model]
2m0y: SOLUTION STRUCTURE OF THE SH3 DOMAIN OF DOCK180 Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
344-401
2m0yA
23%
>target
----------VKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKD--ALGNVGYIPSNYVKPKA-----
>2m0yA
MTRWVPTKREEKYGVAFYNYDARGADELSLQIGDTVHILETY-EGWYRGYTLRKKSKKGIFPASYIHLKEAIVEG
[Model]
2dl3: SOLUTION STRUCTURE OF THE FIRST SH3 DOMAIN OF HUMAN SORBINAND SH3 DOMAIN-CONTAINING PROTEIN 1 Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-401
2dl3A
23%
>target
-------KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPKA-----
>2dl3A
GSSGSSGRPARAKFDFKAQTLKELPLQKGDIVYIYKQIDQNWYEGEH-HGRVGIFPRTYIELLSGPSSG
[Model]
3gqi: CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE INCOMPLEX WITH SUBSTRATES Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
403-506
3gqiB
22%
>target
--------------------------------------------------------------------------------------------------------------------LGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR-----------
>3gqiB
HSSEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPD
[Model]
407-493
3gqiB
26%
>target
--RYEWYVGDMS-----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSG------------------------------------------------------------------------------------------------------------------------------
>3gqiB
HSSEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPD
[Model]
4ey0: STRUCTURE OF TANDEM SH2 DOMAINS FROM PLCGAMMA1 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
403-506
4ey0A
22%
>target
------------------------------------------------------------------------------------------------------------------LGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR----------------------
>4ey0A
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
407-495
4ey0A
25%
>target
RYEWYVGDMS-----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSGGL---------------------------------------------------------------------------------------------------------------------------------------
>4ey0A
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
403-506
4ey0B
22%
>target
------------------------------------------------------------------------------------------------------------------LGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR----------------------
>4ey0B
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
407-495
4ey0B
25%
>target
RYEWYVGDMS-----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSGGL---------------------------------------------------------------------------------------------------------------------------------------
>4ey0B
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
403-506
4ey0C
22%
>target
------------------------------------------------------------------------------------------------------------------LGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR----------------------
>4ey0C
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
407-495
4ey0C
25%
>target
RYEWYVGDMS-----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSGGL---------------------------------------------------------------------------------------------------------------------------------------
>4ey0C
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
403-506
4ey0D
22%
>target
------------------------------------------------------------------------------------------------------------------LGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR----------------------
>4ey0D
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
407-495
4ey0D
25%
>target
RYEWYVGDMS-----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSGGL---------------------------------------------------------------------------------------------------------------------------------------
>4ey0D
NEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDFGAFYVEANPM
[Model]
2fci: STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
402-506
2fciA
22%
>target
--LLGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR---
>2fciA
GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEENSS
[Model]
2pld: NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
402-506
2pldA
22%
>target
--LLGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR---
>2pldA
GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEENSS
[Model]
3u23: ATOMIC RESOLUTION CRYSTAL STRUCTURE OF THE 2ND SH3 DOMAIN Solved by: X-RAY, Resolution: 1.11A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
346-399
3u23A
22%
>target
-LVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKP--
>3u23A
RQCKVLFEYIPQNEDELELKVGDIIDINEEVEEGWWSGTL-NNKLGLFPSNFVKELE
[Model]
2ple: NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
402-506
2pleA
22%
>target
--LLGLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDR---
>2pleA
GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQE--GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEENSS
[Model]
4aaa: CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN Solved by: X-RAY, Resolution: 1.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-775
4aaaA
22%
>target
------MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQR--G------------------IILE----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD-------------------
>4aaaA
LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-G--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAEV-------------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQL
[Model]
2fei: SOLUTION STRUCTURE OF THE SECOND SH3 DOMAIN OF HUMAN CMS PROTEIN Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
345-401
2feiA
21%
>target
-KLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPKA---
>2feiA
MRQCKVLFEYIPQNEDELELKVGDIIDINEEVEEGWWSGTL-NNKLGLFPSNFVKELELEH
[Model]
1e6h: A-SPECTRIN SH3 DOMAIN A11V, M25I, V44I, V58L MUTANTS Solved by: X-RAY, Resolution: 2.01A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
343-400
1e6hA
21%
>target
---FVKLVVALYPFKAIEGGDLSLEKNAEYEVIDDSQEHWWKVKDALGNVGYIPSNYVKPK-
>1e6hA
DETGKELVLVLYDYQEKSPREVTIKKGDILTLLNSTNKDWWKIEV-NDRQGFVPAAYLKKLD
[Model]
1ogu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6- AMINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
523-784
1oguA
19%
>target
---PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD--QLALVAQTL----
>1oguA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
523-785
1oguC
21%
>target
---PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRG--IILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTLT--
>1oguC
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
4bbm: CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
529-775
4bbmA
23%
>target
-----------MEELGS-GQFGVVRRGKWR-GSIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDD-Q-YTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQR--GI-------------------------ILE---KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD-------------------------
>4bbmA
TENLYFQSMEKYENLGLVGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-PNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA
[Model]
529-775
4bbmB
21%
>target
-----MEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRG--I-------------------------IL---EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD-------------------------
>4bbmB
YFQSMEKYENLGSYGMVMKCRNKDTGRIVAIKKFKK------IAMREIKLLKQLRHENLVNLLEV------CYLVFEFVDHTILDDLELFPN-G--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA
[Model]
4fbn: INSIGHTS INTO STRUCTURAL INTEGRATION OF THE PLCGAMMA REGULAND MECHANISM OF AUTOINHIBITION AND ACTIVATION BASED ON KSH2 DOMAINS Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
404-503
4fbnA
23%
>target
------------------------------------------------------------------------------------------------------------------GLERYEWYVGDMSRQRAESLLKQGDKEGCFVVRKSSTKGLYTLSLHTKVPQSHVKHYHIKQNARCEYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSP-----------------------
>4fbnA
NEKWFHGKLGAGDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRA---EGKIKHCRVQQ--EGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGYVEANPM
[Model]
407-557
4fbnA
21%
>target
RYEWYVGDMS----RQRAESLLKQ-----GDKEGCFVVRKSST-KGLYTLSLHTKVPQSHVKHYHIKQNARC---EYYLSEKHCCETIPDLINYHRHNSGGLACRLKSSPCDRPVPPTAGLSHDKWE---IHPMELM-LMEELG-SGQFGVVRRGKWRGSIDTAVKMMK-----------------------------------------------------------------------
>4fbnA
NEKWFHGKLGAGDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWR---NGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRL--SEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVR-KRN--EPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGYVEANPM
[Model]
1h25: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-776
1h25A
20%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ----------
>1h25A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
524-781
1h25C
21%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-------------LEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVA---
>1h25C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
4ez3: CDK2 IN COMPLEX WITH NSC 134199 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
4ez3A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>4ez3A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzi: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qziA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qziA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7e: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r7eA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r7eA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r1q: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r1qA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r1qA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxj: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMI Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pxjA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pxjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8v: CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r8vA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r8vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3py0: CDK2 IN COMPLEX WITH INHIBITOR SU9516 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3py0A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3py0A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r83: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r83A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r83A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzh: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qzhA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qzhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rkb: CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rkbA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rkbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1vyw: STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-782
1vywA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>1vywA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
523-776
1vywC
20%
>target
-PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>1vywC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtz: CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtzA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtzA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qxo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qxoA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qrt: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qrtA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qrtA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk7: CDK2 IN COMPLEX WITH INHIBITOR RC-2-71 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rk7A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rk7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rk5: CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rk5A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rk5A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qx2: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qx2A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qx2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pw2: APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pw2A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pw2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8l: CDK2 IN COMPLEX WITH INHIBITOR L3-4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r8lA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r8lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2b53: HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2b53A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2b53A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2xmy: DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YPYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2xmyA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2xmyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1hcl: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1hclA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1hclA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rjc: CDK2 IN COMPLEX WITH INHIBITOR L4-12 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rjcA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rjcA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2bpm: STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-782
2bpmA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2bpmA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
523-776
2bpmC
20%
>target
-PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2bpmC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cjm: MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATIONCDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-776
2cjmA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------
>2cjmA
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIREG--VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP
[Model]
524-784
2cjmC
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2cjmC
MENFQKVEKIGEGT-GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qqh: CDK2 IN COMPLEX WITH INHIBITOR L2-2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqhA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqhA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r6x: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r6xA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r6xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r71: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r71A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r71A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpv: CDK2 IN COMPLEX WITH INHIBITOR RC-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rpvA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rpvA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7v: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r7vA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r7vA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rm7: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rm7A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rm7A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wih: STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-782
2wihA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2wihA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
523-776
2wihC
20%
>target
-PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2wihC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
4erw: CDK2 IN COMPLEX WITH STAUROSPORINE Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
4erwA
20%
>target
-MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII----------------------------LEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>4erwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLG--VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqf: CDK2 IN COMPLEX WITH INHIBITOR L1 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqfA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqfA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ql8: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3ql8A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3ql8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2jgz: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B Solved by: X-RAY, Resolution: 2.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-775
2jgzA
20%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD------
>2jgzA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD
[Model]
3r1y: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r1yA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r1yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r28: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r28A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r28A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6i: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-776
2c6iA
20%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2c6iA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8p: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r8pA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r8pA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9h: CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r9hA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r9hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3bhu: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 5 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
3bhuA
20%
>target
---MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS-EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>3bhuA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-784
3bhuC
21%
>target
---MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRG--IILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>3bhuC
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qx4: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qx4A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qx4A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ti1: CDK2 IN COMPLEX WITH SUNITINIB Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3ti1A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3ti1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxy: CDK2 IN COMPLEX WITH INHIBITOR JWS648 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3pxyA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3pxyA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzf: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qzfA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qzfA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qwk: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qwkA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qwkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2v0d: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-776
2v0dA
20%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2v0dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtw: CDK2 IN COMPLEX WITH INHIBITOR RC-2-13 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtwA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtwA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rai: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3raiA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3raiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r1s: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r1sA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r1sA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqg: CDK2 IN COMPLEX WITH INHIBITOR L2-5 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqgA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxo: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pxoA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pxoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtu: CDK2 IN COMPLEX WITH INHIBITOR RC-2-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtuA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtuA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3unj: CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3unjA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3unjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qql: CDK2 IN COMPLEX WITH INHIBITOR L3 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqlA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3bht: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 3 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
3bhtA
20%
>target
---MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS-EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>3bhtA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-784
3bhtC
21%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRG--IILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>3bhtC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3rk9: CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rk9A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rk9A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wpa: OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-782
2wpaA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2wpaA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
523-776
2wpaC
20%
>target
-PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2wpaC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3roy: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3royA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3royA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1hck: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1hckA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1hckA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3s00: CDK2 IN COMPLEX WITH INHIBITOR L4-14 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3s00A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3s00A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqj: CDK2 IN COMPLEX WITH INHIBITOR L2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqjA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxr: APO CDK2 CRYSTALLIZED FROM JEFFAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3pxrA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3pxrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r9d: CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r9dA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r9dA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c69: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-776
2c69A
20%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2c69A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rpoA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rpoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxi: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pxiA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pxiA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qzg: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qzgA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qzgA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c6k: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-776
2c6kA
20%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2c6kA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r7y: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r7yA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r7yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h24: CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-776
1h24A
20%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ----------
>1h24A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
524-776
1h24C
20%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ----------
>1h24C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV
[Model]
3bhv: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR VARIOLIN B Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
3bhvA
20%
>target
---MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS-EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>3bhvA
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-784
3bhvC
21%
>target
---MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRG--IILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>3bhvC
GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qtx: CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtxA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtxA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rni: CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rniA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rniA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2wxv: STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
523-776
2wxvC
20%
>target
-PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>2wxvC
DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
521-782
2wxvA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2wxvA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qu0: CDK2 IN COMPLEX WITH INHIBITOR RC-2-38 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qu0A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qu0A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1y8y: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[5-A]PYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-776
1y8yA
20%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ---------------
>1y8yA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qtq: CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtqA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtqA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLN',N'-DIMETHYL-BENZENE-1,4-DIAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pxpA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qqk: CDK2 IN COMPLEX WITH INHIBITOR L4 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qqkA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qqkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1pxn: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)- PYRIMIDIN-2-YLAMINO]-PHENOL Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1pxnA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1pxnA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r73: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r73A
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r73A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3r8u: CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r8uA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r8uA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h27: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1h27A
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1h27A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-785
1h27C
20%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------------ILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTLT--
>1h27C
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3qwj: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qwjA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qwjA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qxp: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qxpA
20%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEKP-----------KSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qxpA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1gih: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
1gihA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------I-----------LEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>1gihA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAV---------------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzl: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
2uzlA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2uzlA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
2uzlC
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2uzlC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3pxq: CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALEN Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
523-784
3pxqA
19%
>target
----PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------L-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>3pxqA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEGV-PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3eoc: CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
3eocA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>3eocA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-784
3eocC
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>3eocC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3tnw: STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
3tnwA
19%
>target
--MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEK-----------PKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>3tnwA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-783
3tnwC
19%
>target
-MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------I-----------LEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD--QLALVAQT--
>3tnwC
MENFQKVEKIGEG--GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP
[Model]
2b54: HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN- 232305 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
2b54A
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2b54A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1ol2: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1ol2A
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1ol2A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
1ol2C
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1ol2C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3unk: CDK2 IN COMPLEX WITH INHIBITOR YL5-083 Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
3unkA
19%
>target
-MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILEK-----------PKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>3unkA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3ej1: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
3ej1A
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>3ej1A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-783
3ej1C
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT-----
>3ej1C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
1e9h: THR 160 PHOSPHORYLATED CDK2-HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1e9hA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1e9hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
1e9hC
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1e9hC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2r3q: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.35A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2r3qA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2r3qA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKITA--------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzb: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
2uzbA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2uzbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
2uzbC
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2uzbC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1oiy: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1oiyA
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1oiyA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
1oiyC
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1oiyC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
3f5x: CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITACTIVE SITE Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3f5xA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3f5xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP-KRISAKAALAHPFFQDVTKPVPHLRL
[Model]
524-782
3f5xC
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>3f5xC
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1jsu: P27(KIP1)/CYCLIN A/CDK2 COMPLEX Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
535-782
1jsuA
19%
>target
GQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------L-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>1jsuA
GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2cch: THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
2cchA
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2cchA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
2cchC
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2cchC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2v22: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDINGGROOVE INHIBITORS Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
2v22C
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2v22C
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
2v22A
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>2v22A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1w98: THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
1w98A
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT-----
>1w98A
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
3r9o: CDK2 IN COMPLEX WITH INHIBITOR RC-2-143 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3r9oA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL-----------------E-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3r9oA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------GVV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vto: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.19A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2vtoA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------L-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2vtoA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFHE------VV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3rpr: CDK2 IN COMPLEX WITH INHIBITOR RC-2-49 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3rprA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL-----------------E-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3rprA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------GVV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vts: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 1.9A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
2vtsA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2vtsA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFHE------VV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3qts: CDK2 IN COMPLEX WITH INHIBITOR RC-2-12 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
3qtsA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL-----------------E-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3qtsA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------GVV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vth: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.0A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
2vthA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------L-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2vthA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1fq1: CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) ICOMPLEX WITH PHOSPHO-CDK2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1fq1B
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1fq1B
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1oiu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
523-784
1oiuA
19%
>target
---PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD--QLALVAQTL----
>1oiuA
PGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
524-784
1oiuC
22%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSE---DDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYT-RFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILEKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1oiuC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL---GVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
1wcc: SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-782
1wccA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>1wccA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRTEG-VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---------V---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1h1p: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1h1pA
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1h1pA
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
524-784
1h1pC
19%
>target
--MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL---
>1h1pC
SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL
[Model]
2xnb: DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YPYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2xnbA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTM-SEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------LE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2xnbA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1b38: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1b38A
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>1b38A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2c4g: STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
521-782
2c4gA
19%
>target
--IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ------
>2c4gA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR
[Model]
521-782
2c4gC
19%
>target
IHPMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQ-------
>2c4gC
VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1gz8: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-783
1gz8A
19%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL-----------------E-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>1gz8A
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRVP----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3f: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
2r3fA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>2r3fA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
1e1x: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-784
1e1xA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------ILE-----------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>1e1xA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3h: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-784
2r3hA
19%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGI-----------------IL-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMD--QLALVAQTL-----
>2r3hA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIP------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2uzn: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2uznA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIILE----------------------------KPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2uznA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIPS------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--------V---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2vtr: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
525-784
2vtrA
19%
>target
--ELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGII-----------------L-----------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQTL-----
>2vtrA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3pxf: CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALSULFONATE Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
523-783
3pxfA
19%
>target
----PMELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMS---EDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNY-TRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>3pxfA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3l: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2r3lA
19%
>target
-MELMLMEELGSGQFGVVRRGKWR-GSIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2r3lA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA----------------TLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
2r3m: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
524-783
2r3mA
19%
>target
-MELMLMEELGSGQFGVVRRGKWRG-SIDTAVKMMKEGTMSEDDFIEEAKVMTKLQHPNLVQLYGVCSKHRPIYIVTEYMKHGSLLNYLRRHEKTLIGNMGLLLDMCIQVSKGMTYLERHNYIHRDLAARNCLVGSENVVKVADFGLARYVLDDQYTSSGGTKFPIKWAPPEVLNYTRFSSKSDVWAYGVLMWEIFTCGKMPYGRLKNTEVVERVQRGIIL----------------------------EKPKSCAKEIYDVMKLCWSHGPEERPAFRVLMDQ--LALVAQT------
>2r3mA
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIVP-----STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAREV------------VTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
[Model]
3fz1: CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2) Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe <